Company profileNeimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria.
Neimeth International Pharmaceuticals Plc (NEIMETH) is listed on NGX in the HEALTHCARE sector, with exposure to Pharmaceutical Preparations. This page brings together the current share price, valuation, dividend context, business summary, and a practical current view so you can assess the stock faster.
Why this stock may reactDirect company signals
capital_raise
NEIMETH may benefit from capital_raise. Confidence 95%.
Shareholders unanimously approved the board's plan to raise additional capital to accelerate expansion and finish the Amawbia manufacturing facility.
fresh capital to fund expansion
NEIMETH may benefit from fresh capital to fund expansion. Confidence 95%.
Shareholders unanimously approved the board's plan to raise additional capital to accelerate expansion and complete the Amawbia manufacturing facility.
profit_taking
NEIMETH may move with profit_taking. Confidence 90%.
Market-wide sell-side pressure across major counters implies sector equities, including consumer goods, were likely impacted.
